Commit To Purchase Enliven Therapeutics At $10, Earn 11.2% Annualized Using Options
April 26, 2024 at 12:37 PM EDT
Investors considering a purchase of Enliven Therapeutics Inc (ELVN) stock, but cautious about paying the going market price of $16.61/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $10 strike, which has a bid at the time of this writing of 45 cents..